PLUS1
Best deals to access real time data! |
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Canadian Level 1 + USA
Monthly Subscription
for only
|
|
Ultimate Trader (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
|
After Hours Last Trade |
Last: $ 79.40 ◊ 0.00 (0.00%) | |
| Company Name | Stock Ticker Symbol | Market | Type | ISIN | Company Description |
|---|---|---|---|---|---|
| Neurocrine Biosciences, Inc. | NBIX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | High Price | Low Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| +1.22 | +1.56% | 79.4 | 80.42 | 77.01 | 78 | 78.18 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 76.45 | 90 | 13.55 | 15.06% | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 5,907 | 600,025 | $ 79.4513 | $ 47.67M | 749.65k | 41.76 - 92.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 16:45:03 | formt | 318 | $79.40 | USD |
Neurocrine Biosciences, Inc. Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 7.14B | 89.88M | $ -142.54M | -1.62 | 0.00 | 75.36M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ 0.00 | 0.00% | -37.59k | 96.50% |
Neurocrine Biosciences, Inc. News
| Date | Time | Source | News Article |
|---|---|---|---|
| 4/18/2018 | 16:01 | PR Newswire (US) | Neurocrine Biosciences to Present New Data from INGREZZA® at.. |
| 4/10/2018 | 08:15 | PR Newswire (US) | AbbVie and Neurocrine Biosciences Announce PDUFA Target Date.. |
| 4/05/2018 | 18:53 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 4/04/2018 | 17:19 | Edgar (US Regulatory) | Additional Proxy Soliciting Materials (definitive) (defa14a) |
| 4/04/2018 | 17:17 | Edgar (US Regulatory) | Proxy Statement (definitive) (def 14a) |
| 3/07/2018 | 16:20 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
| 3/07/2018 | 16:19 | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) |
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical NBIX Price Data
| Period † | Open | High | Low | VWAP | Min Vol | Max Vol | Avg. Daily Vol [m] | Change | % |
|---|---|---|---|---|---|---|---|---|---|
| 1 Week | 76.01 | 80.6 | 74.34 | 77.1896 | 589k | 995k | 737k | 3.39 | 4.46% |
| 1 Month | 84.02 | 84.92 | 74.34 | 78.8554 | 461k | 2M | 802k | -4.62 | -5.50% |
| 3 Months | 87.72 | 92.98 | 74.34 | 83.5750 | 453k | 2M | 788k | -8.32 | -9.48% |
| 6 Months | 58.59 | 92.98 | 57.71 | 77.7032 | 300k | 6M | 901k | 20.81 | 35.52% |
| 1 Year | 51.3 | 92.98 | 41.76 | 63.8901 | 300k | 6M | 940k | 28.1 | 54.78% |
| 3 Years | 43.54 | 92.98 | 31.25 | 51.3593 | 312 | 13M | 952k | 35.86 | 82.36% |
| 5 Years | 11.95 | 92.98 | 8.57 | 39.5238 | 25 | 19M | 903k | 67.45 | 564.44% |
Neurocrine Biosciences, Inc. Description
| Neurocrine Biosciences, Inc., discovers, develops and commercializes drugs for the treatment of neurological and endocrine-related diseases and disorders. |
